Page results
-
Our neonatal service is a recognised centre of excellence caring for acutely ill and preterm babies from our local area and beyond.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.
-
This page has been written to answer some common questions about Tofersen treatment for patients, as well as their caregivers and families.
-
A surgical operation normally carried out to correct a blocked nasal passage may help patients who lost their sense of smell after contracting a COVID-19 infection, according to new research from UCLH.
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
This page has been written for patients who wish to find out more about a new procedure for epilepsy that does not involve removing parts of brain, known as EASEE® (Epicranial Application of Stimulation Electrodes for Epilepsy)
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
This page explains what FACETS is and how it can help you.
File results
-
FOI/2021/0643 - Bank and agency staffing vacancy rates and spending
-
FOI/2021/0644 - Clinical guidelines on identification and management of maternity issues
-
FOI/2021/0645 - Software suppliers for various applications
-
FOI/2021/0649 - Physiotherapists/ occupational therapists staffing levels
-
FOI/2021/0650 - Cyber Essentials Accreditation/ Certification
-
FOI/2021/0657 - Patient list for Neuropsychiatry
-
FOI/2021/0653 - Patient Quality Safety Committee in July 2021
-
FOI/2021/0672 - Long Covid statistics
-
FOI/2021/0691 - MHPS investigations
-
FOI/2021/0700 - Treatment of rare diseases